Skip to main content
. Author manuscript; available in PMC: 2012 Jun 13.
Published in final edited form as: Brain Res. 2011 Apr 22;1395:94–107. doi: 10.1016/j.brainres.2011.04.036

Table 1.

Experimental sample sizes

Parameters for analysis:
AAV Treatment
Group
Morphology Forelimb
Use – 9 wk
Nigrostriatal-
projecting DA
neurons – 9 wk
DA/DA
metabolites –
9 wk
hSNCA N/A 16 9 N/A
hSNCA+hrGFP 4wk-n=10
9wk-n=7
7 n.d. 5
hSNCA+shRNA-
Luc
4wk-n=4
9wk-n=5
4 n.d. 3
hSNCA+shRNA-
SNCA
4wk-n=3
9wk-n=8
28 10 6
shRNA-Luc 9wk-n=4 5 n.d. 4
shRNA-SNCA 9wk-n=9 21 6 6

n.d., not determined